Skip to main content

Infectious Diseases Clinical Trials

The following searchable list includes all the Division of Infectious Diseases - Department of Medicine clinical trials currently looking for participants. Please feel free to contact us with inquiries about any of our ongoing research.

Trials

A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults

ACTT-4 will evaluate the combination of baricitinib and remdesivir compared to dexamethasone and remdesivir in adult patients hospitalized with COVID-19 and requiring supplemental oxygen administered by low flow, high flow, or non-invasive mechanical ventilation.  …
ACTT-4 will evaluate the combination of baricitinib and remdesivir compared to dexamethasone and remdesivir in adult patients hospitalized with COVID-19 and requiring supplemental oxygen administered by low flow, high flow, or non-invasive mechanical ventilation. 

Hospitalized adults (>18 years) with symptoms suggestive of COVID-19

Illness of any duration and laboratory-confirmed SARS-CoV-2 infection within 14 days

Requires low or high flow oxygen devices or non-invasive mechanical ventilation

Has not received 5 or more doses of remdesivir as treatment for COVID-19

Has not receive 6mg or more of dexamethasone in one day, on more than one day in the past 7 days

Taiwo, Babafemi OTaiwo, Babafemi O
  • Map it 201 E. Huron St.
    Chicago, IL
NCT04280705 STU00212207
More Info
Copy